After Hours Summary: SLP +8.5%, VOXX -23%, CUDA -5% following earnings/guidance, RCII +17% on potential Vintage Capital bidAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SLP +8.5%
Companies trading higher in after hours in reaction to news: ARNA +39.7% (announces 'positive' Phase 2 results for ralinepag for the treatment of pulmonary arterial hypertension), WMLP +17.2% (after spiking ~1 point/50% higher in late trade), RCII +17.1% (on reports that Vintage Capital sent letter with buyout proposal), NEOT +13.2% (to initiate process to explore and review strategic alternatives focusing on seeking an acquisition, business combination or partnership), OCUL +11.2% (Ocular Therapeutix submits details of a manufacturing equipment change as an amendment to the NDA resubmission for DEXTENZA 0.4 mg, for intracanalicular use, for the treatment of ocular pain following ophthalmic surgery currently under review by FDA), DRYS +8.2% (announces motion for temporary restraining order to suspend further issuances of common shares below a certain price was denied), PRTA +3% (initiated with Buy rating at Jefferies), KEY +0.8% (upgraded to Outperform from Market Perform at Keefe Bruyette after the close), KTWO +0.6% (signs new, long-term, exclusive agreement with Mitsubishi)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: VOXX -23.2%, CUDA -5.3%, CTXS -3.7% (announces leadership transition to accelerate cloud transformation, enhance profitability and return capital to shareholders; reaffirms Q2 guidance)
Companies trading lower in after hours in reaction to news: YUMA -8.1% (after closing near highs up 190% on the day), GTY -7.7% (launches underwritten registered public offering of 4.1 mln shares of its common stock), ZN -3.2% (continued weakness), SHLO -3% (commences 5 mln common stock offering), OMED -2.2% (OncoMed Pharma received a letter indicating that GSK was terminating Research and Development Collaboration), KN -2.1% (indicated lower on block trade pricing), JCP -1.3% (CFO Edward Record to step down effective July 11 to pursue other interests; company reaffirms expectation to report significantly improved top-line results this quarter versus the first quarter)
Closing Market Summary: S&P 500 Registers Slim Victory On MondayThe stock market kicked off the week with a rather uneventful, range-bound session that left the S&P 500 (+0.1%) just a step above its unchanged mark. The Nasdaq (+0.4%) outperformed the benchmark index while the Dow (unch) lagged, settling just a tick below its flat line. The major averages were hovering at their best marks of the day with less than 30 minutes to go in Monday's session, but a late bout of selling knocked them back to the middle of their trading ranges.
Sector movement was fairly modest throughout the first half of Monday's session, but things picked up a little bit in the afternoon. In general, cyclical sectors outperformed their countercyclical peers with growth-sensitive groups like technology (+0.8%), materials (+0.6%), energy (+0.3%), industrials (+0.2%), and consumer discretionary (+0.2%) settling in the green and defensive-oriented groups like health care (-0.3%), consumer staples (-0.7%), utilities (-0.2%), and telecom services (-0.5%) finishing in the red.
However, the cyclical vs countercyclical narrative doesn't fit Monday's session perfectly as the cyclical financial sector (-0.2%) struggled from the jump. The heavily-weighted group will remain a focal point this week as large-cap financial names like JPMorgan Chase (JPM 93.19, -0.66), Citigroup (C 67.65, -0.26), and Wells Fargo (WFC 55.59, -0.15) prepare to unofficially kick off earnings season with the release of their quarterly reports on Friday.
The top-weighted technology sector started the week with a solid performance that underpinned the broader market from virtually start to finish. The sector benefited from broad strength with chipmakers showing particular resolve, evidenced by the 1.2% increase in the PHLX Semiconductor Index. NVIDIA (NVDA 153.70, +6.94) led the semiconductor advance, jumping 4.7%, after the company's target price was raised to $200 at Needham.
Conversely, the consumer staples space registered a notable decline with Dow component Wal-Mart (WMT 73.23, -2.10) leading the retreat. The big-box retailer dropped 2.8% to a fresh three-month low with some traders citing Amazon's (AMZN 996.47, +17.71) third-annual Prime Day--a day in which the online retail giant offers Black Friday-types of deals to its Prime subscribers--as the catalyst to WMT's underperformance.
In the bond market, U.S. Treasuries settled Monday higher across the curve with the benchmark 10-yr yield dropping two basis points to 2.37%. Meanwhile, the U.S. Dollar Index (95.80, +0.02) finished flat.
Reviewing Monday's economic data, which was limited to May Consumer Credit:
- The Consumer Credit report for May showed an increase of $18.4 billion while the consensus expected growth of $12.7 billion. The prior month's credit growth was revised to $12.9 billion from $8.1 billion.
- Provided consumers weren't making greater use of revolving credit lines to cover basic needs due to a shortfall in income, this report can ostensibly be looked upon as a good sign for the economy since the expansion of credit is an integral contributor to economic growth. It is hard to say, though, because there isn't enough detail in the report and it tends to be subject to large revisions, which is why the market rarely shows much reaction to it.
Economic data will be limited again on Tuesday with investors receiving just two reports--May Wholesale Inventories (consensus 0.3%) and May JOLTS. Both reports will be released at 10:00 ET.
- Nasdaq Composite +14.7% YTD
- S&P 500 +8.4% YTD
- Dow Jones Industrial Average +8.3% YTD
- Russell 2000 +3.8% YTD
In reaction to disappointing earnings/guidance:
- N/A
- SU -0.8%, RDS.A -0.6%, BP -0.6%, OXY -0.5%, RIG -0.5%
- ITEK -47.8% (announces 'no meaningful clinical advantage in IOP reduction' from its Phase 2 trial of trabodenoson and latanoprost for the treatment of glaucoma, announces it is exploring strategic alternatives)
- NXTD -12.8% (enters into definitive agreements with existing institutional investors to purchase an aggregate of approximately $3,432,000 of shares of common stock in a registered direct offering and common stock purchase warrants in a concurrent private)
- USAT -3.8% (files for $40 mln offering of common stock)
- LUV -1.7% (June Traffic)
- SHPG -1.5% (obtained a preliminary injunction in a court of Hamburg against Roche (RHHBY) to address incomplete and misleading statements regarding Emicizumab)
- COOL -0.7% (files for $100 mln mixed securities shelf offering)
- KBH -2.3% (downgraded to Underperform at Mizuho)
- INTC -1.6% (downgraded to Underperform from Hold at Jefferies)
- COST -0.7% (downgraded to Market Perform from Outperform at BMO Capital)
- SUN -0.7% (downgraded to Underperform at Mizuho)